non-muscle invasive bladder cance
Conditions
Interventions
Control group1:Sequential ordinary WLC examination
Control group2:NBI combined with CO2 air cystoscopy
Experimental group:Sequence of ordinary WLC examination and NBI combined with CO2 cystoscopy were performed
Sponsors
Xi'an International Medical Center Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Newly treated patients with non-muscle invasive bladder cancer who have not received radiotherapy and chemotherapy before surgery, the clinical and pathological stages of the tumor are Ta, Tis, T1; G1~G3, no distant metastasis; 2. The patient only underwent transurethral resection of bladder tumor; 3. The patient is older than 18 years old; 4. Sign the informed consent; 5. Expected survival period > 3 months; and KPS score >= 70; 6. Laboratory test results meet the following conditions: WBC>=3.5x10^9/L; Hb>=90 g/L; plt>=100x10^9/L; liver function: AST<2 ULN.
Exclusion criteria
Exclusion criteria: 1. Muscle-invasive bladder cancer (T2~4Nx~3Mx~1); 2. Those with serious uncontrolled medical diseases or acute infection accompanied by other serious diseases; 3. Serious liver and kidney dysfunction such as severe jaundice (serum bilirubin>50µmol/L) ALT>120µ/L coagulation dysfunction; 4. White blood cells 7.0mmol/l (126mg/dl); 9. Poor blood pressure control in hypertension (systolic blood pressure>=160mmHg and diastolic blood pressure>=100mmHg after treatment).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pathologic result;adverse reactions;1 year recurrence rate; | — |
Countries
China
Contacts
Public ContactChen Yong
Department of Urology, Xi'an International Medical Center Hospital
Outcome results
None listed